Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
PaperCitations, authors & open-access status
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 164 citations, 2017 year and hybrid oa status.
164
Citations
2017
Year
hybrid
OA Status